<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02445014</url>
  </required_header>
  <id_info>
    <org_study_id>2014-P-002058</org_study_id>
    <secondary_id>1R01CA184102-01</secondary_id>
    <nct_id>NCT02445014</nct_id>
  </id_info>
  <brief_title>Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule</brief_title>
  <acronym>SECM</acronym>
  <official_title>Pilot Study for Imaging of Barrett's Esophagus Using an Spectrally Encoded Confocal Microscopy Tethered Endoscopic Capsule</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this research is to test the feasibility and tolerability of the modified, larger
      diameter, tethered Spectrally Encoded Confocal Microscopy (SECM) capsule in healthy subjects,
      subjects with Barrett's Esophagus (BE), and subjects with Gastroesophageal reflux disease
      (GERD). This information will be used to assess optimal imaging technique, imaging quality,
      and subject tolerability.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      36 subjects including 12 healthy volunteers, 12 patients with Barrett's Esophagus and 12 with
      Gastroesophageal reflux disease will be enrolled and asked to swallow the SECM HITEC Capsule.
      The subjects will be awake and unsedated.

      The capsule is attached to a string like tether which allows the operator to control as well
      as navigate the capsule as it progresses down the esophagus using natural propulsive force
      called peristalsis.

      As the capsule progresses through the esophagus, multiple images of the esophagus are
      acquired in real time to be analyzed later.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility for imaging of Esophagus using an SECM tethered endoscopic capsule.</measure>
    <time_frame>20 minute visit (5-7 minute imaging)</time_frame>
    <description>SECM images will be assessed for quality and identification of histological features</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability of swallowing the SECM tethered endoscopic capsule</measure>
    <time_frame>20 minute visit (+/-1-2 minute swallowing time)</time_frame>
    <description>Subjects will be asked about tolerability. Study staff will assess the ease of use</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Healthy</condition>
  <condition>Barrett's Esophagus</condition>
  <condition>Gastric Acid Reflux</condition>
  <arm_group>
    <arm_group_label>MGH SECM Imaging Capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will swallow the SECM imaging capsule and images will be acquired using the SECM Imaging system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MGH SECM Imaging Capsule</intervention_name>
    <description>Imaging of the Esophagus using the SECM capsule and SECM Imaging system</description>
    <arm_group_label>MGH SECM Imaging Capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must be 1) a healthy volunteer (18 years or older), or 2) a subject with
             prior diagnosis of BE (18 years or older), or 3) a subject with prior diagnosis of
             GERD (18 years or older).

          -  AND Subject must be able to give informed consent.

          -  AND Subject must eat no solid foods for 8 hours before the procedure and only clear
             liquids for 2 hours before the procedure.

        Exclusion Criteria:

          -  Subjects with any history of or known upper gastrointestinal strictures

          -  OR Subjects with a history of Crohn's disease,

          -  OR Subjects with difficulty swallow
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillermo J Tearney, MD., PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillermo J Tearney, MD., PhD</last_name>
    <phone>617-724-2979</phone>
    <email>gtearney@mgh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mireille Rosenberg, PhD</last_name>
    <phone>617-726-9145</phone>
    <email>mrosenberg@mgh.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillermo Tearney, MD</last_name>
      <phone>617-724-2979</phone>
      <email>gtearney@partners.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2015</study_first_submitted>
  <study_first_submitted_qc>May 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2015</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Guillermo Tearney</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Barrett's</keyword>
  <keyword>GERD</keyword>
  <keyword>Capsule</keyword>
  <keyword>SECM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Barrett Esophagus</mesh_term>
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Heartburn</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

